TCG Crossover Management, LLC

Position in TNGX — Tango Therapeutics, Inc.

CIK 1839948 PALO ALTO, CA

Position in TNGX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$220,310,005

+$107,237,853 QoQ

Shares Held

10,531,071

-17.5% QoQ

Ownership

7.28%

of shares outstanding

% of Portfolio

6.29%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

TCG Crossover Management, LLC holds $3,218,747,876 across 44 Biotechnology names. TNGX ranks #3 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	6,481,085	$721,668,814
2	CGON	CG Oncology, Inc.	3,670,206	$248,399,542
3	TNGX	Tango Therapeutics, Inc. This page	10,531,071	$220,310,005
4	COGT	Cogent Biosciences, Inc.	4,946,894	$190,405,950
5	CNTA	Centessa Pharmaceuticals plc	4,286,480	$170,258,985
6	DNTH	Dianthus Therapeutics, Inc. /DE/	1,676,624	$140,702,286
7	TYRA	Tyra Biosciences, Inc.	3,248,980	$124,435,934
8	IMVT	Immunovant, Inc.	4,457,988	$110,736,421

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$220,310,005	10,531,071	-17.5%	Shares	Sole	2026-05-15
2025-12-31	$113,072,152	12,762,094	+49.5%	Shares	Sole	2026-02-17
2025-09-30	$71,704,046	8,536,196	-20.5%	Shares	Sole	2025-11-17
2025-06-30	$54,968,320	10,736,000	0.0%	Shares	Sole	2025-08-14
2025-03-31	$14,708,320	10,736,000	0.0%	Shares	Sole	2025-05-14
2024-12-31	$33,174,240	10,736,000	+815.8%	Shares	Sole	2025-02-14
2022-09-30	$4,243,545	1,172,250	0.0%	Shares	Sole	2022-11-14
2022-06-30	$5,310,292	1,172,250	-6.6%	Shares	Sole	2022-08-15
2022-03-31	$9,509,110	1,254,500	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.